Compounds > fluorescein
Page last updated: 2024-08-22

fluorescein and Benign Mucosal Pemphigoid

fluorescein has been researched along with Benign Mucosal Pemphigoid in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Feng, Y; He, B; He, Y; Ji, Z; Jia, J; Liu, H; Quan, Z; Ren, Y; Zhang, C; Zhang, R1
Kaye, SB; Leong, HL; Somerville, TF; Stewart, RM1
Bandello, F; Berchicci, L; Iuliano, L; Miserocchi, E; Modorati, G1
Fukui, M; Kamoi, M; Kawakita, T; Mukai, S; Ogawa, Y; Saijo-Ban, Y; Simmura, S; Tsubota, K; Yaguchi, S; Yamane, M1

Other Studies

4 other study(ies) available for fluorescein and Benign Mucosal Pemphigoid

ArticleYear
Perioperative Management and Long-Term Outcomes in Ocular Cicatricial Pemphigoid Patients Undergoing Cataract Surgery.
    Oxidative medicine and cellular longevity, 2022, Volume: 2022

    Topics: Cataract; Female; Fluorescein; Humans; Male; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retrospective Studies; Visual Acuity

2022
Oral fluorescein staining in mucous membrane pemphigoid.
    JAMA ophthalmology, 2013, Volume: 131, Issue:3

    Topics: Administration, Oral; Conjunctival Diseases; Female; Fluorescein; Fluorescent Dyes; Humans; Middle Aged; Oral Ulcer; Pemphigoid, Benign Mucous Membrane; Staining and Labeling

2013
Tear film osmolarity in ocular mucous membrane pemphigoid.
    Cornea, 2014, Volume: 33, Issue:7

    Topics: Aged; Conjunctiva; Cornea; Cross-Sectional Studies; Dry Eye Syndromes; Female; Fluorescein; Humans; Immunosuppressive Agents; Lissamine Green Dyes; Male; Osmolar Concentration; Pemphigoid, Benign Mucous Membrane; Surveys and Questionnaires; Tears

2014
Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
    Optometry and vision science : official publication of the American Academy of Optometry, 2015, Volume: 92, Issue:4 Suppl 1

    Topics: Administration, Topical; Aged; Alanine; Drug Therapy, Combination; Dry Eye Syndromes; Enzyme Inhibitors; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Graft vs Host Disease; Humans; Middle Aged; Ophthalmic Solutions; Pemphigoid, Benign Mucous Membrane; Polyphosphates; Purinergic P2Y Receptor Agonists; Quinolones; Treatment Outcome; Uracil Nucleotides; Visual Acuity

2015